The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
A Multinational Survey of Risk Factors for Infection with Extended‐Spectrum β‐Lactamase–Producing Enterobacteriaceae in Nonhospitalized Patients
Abstract
BACKGROUND: Infections caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae are increasing in frequency and are associated with high mortality rates. Circulation of CTX-M-type ESBLs in the community is of particular concern, because it may confound standard infection-control measures. METHODS: We analyzed the results of epidemiologic studies of infection caused by ESBL-producing Enterobacteriaceae in nonhospitalized patients from 6 centers in Europe, Asia, and North America. Risk factors for infection with an ESBL-producing organism were identified by univariate and multivariate analyses. RESULTS: A total of 983 patient-specific isolates were reviewed (890 [90.5%] of which were Escherichia coli, 68 [6.9%] of which were Klebsiella species, and 25 [2.5%] of which were Proteus mirabilis); 339 [34.5%] of the isolates produced ESBLs. CTX-M types were the most frequent ESBLs (accounting for 65%). Rates of co-resistance to ciprofloxacin among ESBL-producing isolates were high (>70%), but significant variation was seen among centers with respect to rates of resistance to gentamicin, amoxicillin-clavulanate, and trimethoprim-sulfamethoxazole. Similar risk factors for infection with an ESBL-producing organism were found in the different participating centers. Significant risk factors, identified by multivariate analysis, were recent antibiotic use, residence in a long-term care facility, recent hospitalization, age 65 years, and male sex (area under the receiver-operator characteristic [ROC] curve, 0.80). However, 34% of ESBL-producing isolates (115 of 336 isolates) were obtained from patients with no recent health care contact; the area under the ROC curve for the multivariate model for this group of patients was only 0.70, which indicated poorer predictive value. CONCLUSIONS: Community-acquired ESBL-producing Enterobacteriaceae are now prevalent worldwide, necessitating international collaboration. Novel approaches are required to adequately address issues such as empirical treatment for severe community-acquired infection and infection control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Katz, S. (1963) · JAMA · doi:10.1001/jama.1963.03060120024016 · Cited by 2,421
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,044
Self-citationGram-Negative Bacteremia: I. Etiology and Ecology
McCABE, W. R. (1962) · Archives of Internal Medicine · doi:10.1001/archinte.1962.03620240029006 · Cited by 1,362
Kreger, B. E., Craven, D. E., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90102-3 · Cited by 1,314
The CTX-M β-lactamase pandemic
Cantón, R., & Coque, T. M. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.08.011 · Cited by 1,147
Health Care Costs and Mortality Associated with Nosocomial Diarrhea Due to Clostridium difficile
Kyne, L., Hamel, M. B., Polavaram, R., & Kelly, C. P. (2002) · Clinical Infectious Diseases · doi:10.1086/338260 · Cited by 904
Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
Pitout, J. D. D., Nordmann, P., Laupland, K. B., & Poirel, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki166 · Cited by 790
Self-citationCoque, T. M., Novais, Â., Carattoli, A., Poirel, L., Pitout, J., Peixe, L., Baquero, F., Cantón, R., & Nordmann, P. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1402.070350 · Cited by 702
Self-citationSchwaber, M. J., & Carmeli, Y. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm318 · Cited by 626
Self-citationSafdar, N., & Maki, D. G. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-11-200206040-00013 · Cited by 556
Tumbarello, M., Sanguinetti, M., Montuori, E., Trecarichi, E. M., Posteraro, B., Fiori, B., Citton, R., D'Inzeo, T., Fadda, G., Cauda, R., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01509-06 · Cited by 461
Rodríguez-Baño, J., Navarro, M. D., Romero, L., Martínez-Martínez, L., Muniain, M. A., Perea, E. J., Pérez-Cano, R., & Pascual, A. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.3.1089-1094.2004 · Cited by 456
Self-citationCommunity Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli
Rodríguez-Baño, J., Alcalá, J. C., Cisneros, J. M., Grill, F., Oliver, A., Horcajada, J. P., Tórtola, T., Mirelis, B., Navarro, G., Cuenca, M., et al. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.17.1897 · Cited by 379
Self-citationColodner, R., Rock, W., Chazan, B., Keller, N., Guy, N., Sakran, W., & Raz, R. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-1084-2 · Cited by 364
Influx of Extended-Spectrum -Lactamase--Producing Enterobacteriaceae into the Hospital
Ben-Ami, R., Schwaber, M. J., Navon-Venezia, S., Schwartz, D., Giladi, M., Chmelnitsky, I., Leavitt, A., & Carmeli, Y. (2006) · Clinical Infectious Diseases · doi:10.1086/500936 · Cited by 317
Self-citationCalbo, E., Romaní, V., Xercavins, M., Gómez, L., Vidal, C. G., Quintana, S., Vila, J., & Garau, J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl035 · Cited by 305
Self-citationArslan, H., Azap, Ö. K., Ergönül, Ö., & Timurkaynak, F. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki344 · Cited by 286
Self-citationLewis, J. S., Herrera, M., Wickes, B., Patterson, J. E., & Jorgensen, J. H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00576-07 · Cited by 231
Pitout, J. D. D., Hanson, N. D., Church, D. L., & Laupland, K. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421094 · Cited by 192
Self-citationKojima, A., Ishii, Y., Ishihara, K., Esaki, H., Asai, T., Oda, C., Tamura, Y., Takahashi, T., & Yamaguchi, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3533-3537.2005 · Cited by 187
Hernández, J. R., Martínez-Martínez, L., Cantón, R., Coque, T. M., & Pascual, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.2122-2125.2005 · Cited by 163
Self-citationSchwaber, M. J., Navon-Venezia, S., Schwartz, D., & Carmeli, Y. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.2137-2139.2005 · Cited by 160
Self-citationArpin, C., Dubois, V., Coulange, L., André, C., Fischer, I., Noury, P., Grobost, F., Brochet, J.-P., Jullin, J., Dutilh, B., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3506-3514.2003 · Cited by 157
Self-citationCarattoli, A., Lovari, S., Franco, A., Cordaro, G., Matteo, P. D., & Battisti, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.833-835.2005 · Cited by 153
Moubareck, C. A., Daoud, Z., Hakimé, N., Hamzé, M., Mangeney, N., Matta, H., Mokhbat, J., Rohban, R., Sarkis, D. K., & Doucet‐Populaire, F. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3309-3313.2005 · Cited by 148
Lavollay, M., Mamlouk, K., Frank, T., Akpabie, A., Burghoffer, B., Redjeb, S. B., Bercion, R., Gautier, V., & Arlet, G. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00150-06 · Cited by 135
Novais, Â., Cantón, R., Valverde, A., Machado, E., Galán, J. C., Peixe, L. M. S. V., Carattoli, A., Baquero, F., & Coque, T. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00274-06 · Cited by 122
Naas, T., Oxacelay, C., & Nordmann, P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00611-06 · Cited by 98
Peña, C., Gudiol, C., Tubau, F., Saballs, M., Pujol, M., Domínguez, M. Á., Calatayud, L., Ariza, J., & Gudiol, F. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01358.x · Cited by 92
Anderson, D. J., Engemann, J. J., Harrell, L. J., Carmeli, Y., Reller, L. B., & Kaye, K. S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1715-1720.2006 · Cited by 87
Self-citation
Cited by
Fernández, J., Acevedo, J., Castro, M., Garcia, O., de Lope, C. R., Roca, D., Pavesi, M., Sola, E., Moreira, L., Silva, A., et al. (2012) · Hepatology · doi:10.1002/hep.25532 · Cited by 620
The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection
Mazuski, J. E., Tessier, J. M., May, A. K., Sawyer, R. G., Nadler, E. P., Rosengart, M. R., Chang, P. K., O'Neill, P. J., Mollen, K. P., Huston, J. M., et al. (2017) · Surgical Infections · doi:10.1089/sur.2016.261 · Cited by 573
Falagas, M. E., Kastoris, A. C., Kapaskelis, A. M., & Karageorgopoulos, D. E. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70325-1 · Cited by 487
Hawkey, P. M., Warren, R. E., Livermore, D. M., McNulty, C. A. M., Enoch, D. A., Otter, J. A., & Wilson, A. P. R. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky027 · Cited by 334
Self-citation2013 WSES guidelines for management of intra-abdominal infections
Sartelli, M., Viale, P., Catena, F., Ansaloni, L., Moore, E., Malangoni, M., Moore, F. A., Velmahos, G., Coimbra, R., Ivatury, R., et al. (2013) · World Journal of Emergency Surgery · doi:10.1186/1749-7922-8-3 · Cited by 314
Metadata
- Authors
- Ben‐Ami, R., Rodríguez‐Baño, J., Arslan, H., Pitout, J. D. D., Quentin, C., Calbo, E. S., Azap, Ö. K., Arpin, C., Pascual, A., Livermore, D. M., Garau, J., & Carmeli, Y.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-09
- Volume
- 49
- Issue
- 5
- Pages
- 682-690
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2142401286
- Cited by
- 462
- References
- 30
- FWCI
- 11.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.